Skip to content
ZP
Company

Updated:

Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001621443, and its reported...

Overview

Zynerba Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001621443, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-28, it reported net income of USD -35,035,806; total assets of USD 55,520,894 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Zynerba Pharmaceuticals, Inc.
Former names in filing history
Zynerba Pharmeceuticals, Inc. (2014-10-09 to 2015-06-30)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Devon, PA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001621443

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD-$35.0M$55.5M$50.6M-$23.0M
FY2021USD-$37.3M$81.2M$67.8M-$33.5M
FY2020USD-$51.3M$74.1M$59.2M-$41.3M
FY2019USD-$32.9M$87.8M$70.1M-$34.8M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
SC 13G—Form SC 13G
8-KFORM 8-K
SC 13D—SC 13D
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
8-KFORM 8-K
DEF 14ADEF 14A
10-K10-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Zynerba Pharmaceuticals, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles